NFKB1 and prostate cancer: The inverse relation between AR and NFκB pathway activity in cancer-adjacent tissue, hyperplasia, and primary PCa is of potential clinical relevance since inflammation is known to be a bad prognostic marker for both benign hyperplasia and prostate cancer and may be associated with hormonal resistance92–94.